Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $15.00 ($45,000)
  2. 4 Open-market sale President and CEO sold 6,526 shares at an average $15.00 ($97,899)
  3. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $18.46 ($55,380)
  4. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.39 ($67,170)
  5. 4 Open-market sale President and CEO sold 13,052 shares at $21.86 ($285,343)
  6. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.05 ($78,150)
  7. 4 Open-market sale President and CEO sold 4,497 shares at $25.06 ($112,689)
  8. 4 Open-market sale President and CEO sold 2,028 shares at $25.09 ($50,880)
  9. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.56 ($67,680)
  10. 4 Open-market sale President and CEO sold 13,052 shares at $23.42 ($305,708)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $25.93 ($77,793)
  18. 4 Grant or award President and CEO acquired 302 shares (grant or award)
  19. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.52 ($79,562)
  20. 4 Open-market sale President and CEO sold 19,578 shares at $26.55 ($519,743)

Page 12 of 20 · 400 filings